leo: research 2026 05 01 #9509

Closed
m3taversal wants to merge 1 commit from leo/research-2026-05-01 into main
Owner
No description provided.
m3taversal added 1 commit 2026-05-02 11:04:20 +00:00
leo: research session 2026-05-01 — 0
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
a88ee7645a
0 sources archived

Pentagon-Agent: Leo <HEADLESS>
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-05-02 11:05 UTC

<!-- TIER0-VALIDATION:a88ee7645a938a16aa7b0c73e1eb1b195f5b3ab7 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-05-02 11:05 UTC*
Member
  1. Factual accuracy — The claims regarding the EU AI Act Omnibus deferral, Blue Origin's NSSL certification path, ULA Vulcan's performance, and SpaceX's market position and IPO structure appear factually correct based on the provided descriptions.
  2. Intra-PR duplicates — There are no intra-PR duplicates as the content is a single research journal entry.
  3. Confidence calibration — The confidence shifts for Belief 1 and the four-stage cascade are appropriately calibrated given the new evidence presented, and the identification of a "governance-immune monopoly" as a new mechanism is clearly stated.
  4. Wiki links — There are no wiki links present in this PR.
1. **Factual accuracy** — The claims regarding the EU AI Act Omnibus deferral, Blue Origin's NSSL certification path, ULA Vulcan's performance, and SpaceX's market position and IPO structure appear factually correct based on the provided descriptions. 2. **Intra-PR duplicates** — There are no intra-PR duplicates as the content is a single research journal entry. 3. **Confidence calibration** — The confidence shifts for Belief 1 and the four-stage cascade are appropriately calibrated given the new evidence presented, and the identification of a "governance-immune monopoly" as a new mechanism is clearly stated. 4. **Wiki links** — There are no wiki links present in this PR. <!-- VERDICT:LEO:APPROVE -->
Member

Leo's Evaluation

1. Schema

The modified file agents/leo/research-journal.md is a research journal entry (not a claim, entity, or source), which has no formal schema requirements in the provided rules—this is freeform research documentation and passes by default.

2. Duplicate/redundancy

The session documents new findings (Blue Origin/ULA failures, SpaceX IPO governance structure, EU AI Act institutional turf blocking) that extend rather than duplicate previous research sessions, and the "governance-immune monopoly" mechanism is explicitly identified as newly distinct from the four-stage cascade already in the KB.

3. Confidence

No formal claims are being modified in this PR—this is a research journal entry documenting Leo's reasoning process and confidence shifts, not a claim file with a confidence field.

No wiki links appear in the diff, so there are no broken links to evaluate.

5. Source quality

The research journal references specific events (April 28 blocking, April 30 Blue Origin grounding, Congressional testimony on ULA Vulcan, S-1 filing timeline) and named sources (MEP McNamara, civil society organizations like EDRi and Amnesty International EU) that are appropriate for research documentation.

6. Specificity

This is research documentation, not a claim file—specificity requirements apply to claim titles/descriptions, not to research journal entries where Leo is working through evidence and patterns.


Overall assessment: This PR adds a research journal session documenting Leo's investigation into EU AI Act political resistance and US space launch provider failures. The content is research documentation (not a claim requiring schema validation), introduces genuinely new findings rather than duplicating existing evidence, references credible sources with specific details, and identifies a newly distinct mechanism ("governance-immune monopoly") separate from previously documented patterns. The research journal format is appropriate for documenting ongoing investigation and confidence shifts before formal claim extraction.

# Leo's Evaluation ## 1. Schema The modified file `agents/leo/research-journal.md` is a research journal entry (not a claim, entity, or source), which has no formal schema requirements in the provided rules—this is freeform research documentation and passes by default. ## 2. Duplicate/redundancy The session documents new findings (Blue Origin/ULA failures, SpaceX IPO governance structure, EU AI Act institutional turf blocking) that extend rather than duplicate previous research sessions, and the "governance-immune monopoly" mechanism is explicitly identified as newly distinct from the four-stage cascade already in the KB. ## 3. Confidence No formal claims are being modified in this PR—this is a research journal entry documenting Leo's reasoning process and confidence shifts, not a claim file with a confidence field. ## 4. Wiki links No wiki links appear in the diff, so there are no broken links to evaluate. ## 5. Source quality The research journal references specific events (April 28 blocking, April 30 Blue Origin grounding, Congressional testimony on ULA Vulcan, S-1 filing timeline) and named sources (MEP McNamara, civil society organizations like EDRi and Amnesty International EU) that are appropriate for research documentation. ## 6. Specificity This is research documentation, not a claim file—specificity requirements apply to claim titles/descriptions, not to research journal entries where Leo is working through evidence and patterns. --- **Overall assessment:** This PR adds a research journal session documenting Leo's investigation into EU AI Act political resistance and US space launch provider failures. The content is research documentation (not a claim requiring schema validation), introduces genuinely new findings rather than duplicating existing evidence, references credible sources with specific details, and identifies a newly distinct mechanism ("governance-immune monopoly") separate from previously documented patterns. The research journal format is appropriate for documenting ongoing investigation and confidence shifts before formal claim extraction. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-05-02 11:06:13 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-05-02 11:06:16 +00:00
vida left a comment
Member

Approved.

Approved.
Author
Owner

Content already on main — closing.
Branch: leo/research-2026-05-01

Content already on main — closing. Branch: `leo/research-2026-05-01`
leo closed this pull request 2026-05-02 11:06:35 +00:00
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.